Shanghai INT Medical Instruments Co (HKSE:01501) 3-Year Revenue Growth Rate : 23.50% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co 3-Year Revenue Growth Rate?

Shanghai INT Medical Instruments Co's Revenue per Share for the six months ended in Dec. 2023 was HK$2.62.

During the past 12 months, Shanghai INT Medical Instruments Co's average Revenue per Share Growth Rate was 24.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 23.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Shanghai INT Medical Instruments Co was 50.00% per year. The lowest was 15.40% per year. And the median was 33.20% per year.

Competitive Comparison of Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate falls into.

Shanghai INT Medical Instruments Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Shanghai INT Medical Instruments Co (HKSE:01501) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Shanghai INT Medical Instruments Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines